Valid Insight’s launch aims to meet the market access challenges facing new medicines, helping life science research to translate into real-world benefits for patients and society
London, UK, February 23, 2016 / B3C newswire / -- Dr Steve Bradshaw, leading a team of key life science advisors and industry experts, has launched Valid Insight, a new market access consultancy created to help drug developers navigate the challenges of market access for new and innovative therapeutics.
Getting new medicines and health technologies to patients who need better treatment is becoming increasingly testing, and payers and health technology assessment bodies are demanding growing levels of evidence to show real-world value.
Valid Insight’s advisors have decades of specialist experience and business knowledge in market access, health economics, outcomes research, and product and health technology launch, pricing and reimbursement. They understand the complexity of the life science landscape and the challenges and hurdles faced by manufacturers, payers, prescribers and patients in demonstrating real-world value.
“We are investing considerable resources in developing our expertise, methods and offerings, including real-world evidence, that help our clients optimize the commercial success of their products,” said Dr Bradshaw, Valid Insight founder and managing director. “I believe that the launch of Valid Insight, and the experts we have on board, will help our clients to build the global landscape of tomorrow’s healthcare environment and deliver better outcomes to patients and society.” The Valid Insight team will put its expertise to work to provide integrated and strategic research, analysis and value communication solutions to create insight into the market and clinical opportunity, develop evidence, communicate value and build and support centres of excellence through education and training. Its core services are based on its wealth of real in-house expertise and on primary and secondary research, including real-world evidence and research with key opinion leaders and payers.
Valid Insight will be exhibiting at London’s Pharma Pricing and Market Access Congress 2016 on 24-25 February, and the Orphan Drugs and Rare Disease Global Congress at Olympia in March.
About Valid Insight
Valid Insight is a life science consulting firm specialising in value strategy for health technologies. Valid Insight partners with life science organisations worldwide to optimize the market access and real-world commercial success of their products by leveraging knowledge of the global payer and regulator landscape and by developing, capturing and communicating the clinical and economic evidence that clients require to successfully market their products. Valid Insight research and strategy consulting services are delivered by a team of recognised experts and thought leaders who together combine specialist commercial, scientific and clinical capabilities.
